Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: paclitaxel|DRUG: sorafenib tosylate|OTHER: placebo
Sponsor: Northwestern University
Collaborators: Amgen